Prasad’s predecessor in at FDA, Dr. Peter Marks, oversaw a dramatic rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of ...

Prasad’s predecessor in at FDA, Dr. Peter Marks, oversaw a dramatic rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of ...

FDA vaccine chief Dr. Vinay Prasad resigns following controversies over gene therapy approvals, sparking criticism from Trump allies and patient groups ...

Dr Peter Marks, director of the FDA Center for Biologics Evaluation and Research told a packed house in San Francisco for JPM that FDA wants to support gene therapies in 2024.

Since taking office, President Donald Trump has brusquely removed a number of top officials from their positions, including a ...

Prasad—who took on additional roles as the FDA’s chief medical and scientific officer—succeeded Peter Marks, MD, who suddenly tendered his resignation after clashing over vaccine policy with ...

Prasad was a vocal opponent of his predecessor Peter Marks, who ran CBER for nearly a decade before resigning in March after a dispute with HHS Secretary Robert F. Kennedy Jr. Marks championed ...

A longtime critic of federal pandemic policy, Prasad was brought in this May to replace Dr. Peter Marks as head of the FDA’s Center for Biologics Evaluation and Research.

Prasad was named head of the FDA’s Center for Biologics Evaluation and Research in early May as a replacement for Peter Marks, the longtime leader of division who resigned in March after ...